Services, Woburn, MA) (3) . The specific activity of the TNF(LuKII) preparation was 1.5 X 107 U/mg of protein. Mouse serum TNF was purified by DEAE and G-100 Sephadex column chromatography and had a specific activity of 5 x 104 U/mg of protein. A more highly purified preparation of mouse TNF (1 X 106 U/mg protein) was a gift of Dr. K. Haranaka.
TNF assays were performed in 96-well microtiter plates. TNF-sensitive L(M) cells were added at a density of 2 x 104 cells/well in 100 #1 to fractions of TNF serially diluted twofold. After 2 d at 37°C, the plates were examined microscopically and the percentage of the killed cells was determined. The number of units of sample was calculated as the reciprocal of the highest dilution that killed 50% of the cells. All TNF assays were run in parallel with a TNF(LuKII) laboratory standard and all titers are expressed in laboratory units.
Radioiodination of TNF(LuKII)
. TNF(LuKII) was labeled with lz~I using 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril (Iodo-gen; Pierce Chemical Co., Rockford, IL) in the following manner. Polypropylene tubes were coated with 100 #g of Iodo-gen (dissolved in chloroform) by evaporation of the solvent. A sample of TNF(LuKII) containing 160,000 U/ml (as assayed in duplicate on three occasions) in 3 ml was incubated for 25 min at room temperature in an Iodo-gen-coated tube containing 6 mCi of 1~5I. The labeled protein was then separated from the unbound 125I using a P-4 column (Bio-Rad Laboratories, Richmond, CA) equilibrated with phosphate-buffered saline (PBS) containing 50 ttg/ml of cytochrome c. The iodinated material eluted in the void volume of the column in 8 ml and was divided into aliquots before storing at -80°C. It was assayed for biological activity six times on separate occasions and was found to contain 60,000 U/ml and 7.5 × 109 cpm/mg of TNF(LuKII). Thus, radioiodination of TNF(LuKII) did not result in any apparent loss of biological activity.
Assay for the Binding of t25I-labeled TNF(LuKII) to Cells. L(M) cells and TNF-resistant
subclones of L(M) cells seeded in 25-cm 2 flasks at a density of 2 X 106 cells per flask were allowed to adhere to the flasks for 24 h before exposure to ~I-labeled TNF(LuKII); at this time, the flasks contained ~3.5 x 106 cells per flask. HeLa cells seeded in 25-cm ~ flasks at a density of 1.5 X 106 cells per flask were allowed to adhere to the flasks for 48 h before exposure to ~25I-labeled TNF(LuKII); at this time, the flasks contained ~5 x 106 cells per flask. ~25I-labeled TNF(LuKII) was added to the flasks in 1 ml Eagle's minimum essential medium (MEM), containing 10% fetal bovine serum (Gibco Laboratories, Grand Island, NY). Amounts of TNF and time intervals are described in the figure legends. After the indicated incubation period, the cells were washed three times with cold PBS, scraped from the flask in PBS, and centrifuged at 15,000 g for 5 min over a cushion of PBS containing 5% sucrose. The sucrose cushion was then removed and the cell pellets counted in a gamma radiation counter. Specific binding of the radiolabeled TNF(LuKII) was determined by subtracting the number of counts bound to cells in the presence of an excess of nonlabeled TNF(LuKII) from the number of counts in the presence of tesIlabeled TNF(LuKII) alone. The amount of nonlabeled TNF(LuKII) used in each experiment is stated in the figure legends. Nonspecific binding of ~SI-labeled TNF(LuKII) was not >15 cpm in any experiment.
Results
Mouse L(M) cells and HeLa cells (a line derived from human cervical carcinoma) are sensitive to the cytotoxic effect of TNF(LuKII) and mouse TNF. L cells can be rendered resistant to TNF by repeated passage in TNF-containing medium, and two sublines of TNF-resistant L(M) cells have been developed: one made resistant to mouse TNF and the other, resistant to TNF(LuKII). Resistance to mouse TNF renders the cells resistant to TNF(LuKII), and vice versa.
As a first step, we examined the time course of binding of ~25I-labeled TNF(LuKII) to the L(M) cells, L(M) cells resistant to TNF(LuKII), and HeLa cells. As shown in Fig. 1 Quantitative competition experiments revealed that the binding of 125I-labeled TNF(LuKII) to L(M) or HeLa cells is equally inhibited by nonlabeled TNF(LuKII) and mouse TNF (Fig. 2) .
To determine whether binding of TNF(LuKII) to the cells was occurring via a saturable receptor, we incubated L(M) and HeLa cells with increasing concentrations of ]25I-labeled TNF(LuKII) for 5 h at 4°C and measured the uptake. Sites for TNF(LuKII) on L(M) and HeLa cell lines are half saturable at a TNF(LuKII) concentration of-100 U/ml, demonstrating the presence of high affinity binding sites (Fig. 3) . Three additional experiments were performed (data not shown) and similar saturation cuFves were observed. Examination of the cytotoxic effect of TNF(LuKII) on L(M) and HeLa cells (Fig. 4) revealed that the receptor saturation curves and the dose response curves are roughly similar in their concentration dependence. Scatchard plots of the data in Fig. 3 are shown in Fig. 5 . Based on TNF(LuKII) having a molecular weight, under nondenaturing conditions, of 70,000 (2, 3) and a specific activity of 1.5 × 10 7 U/mg of protein, we calculate the number of TNF receptors to be approximately 200 and 300 for the L(M) and HeLa cell lines, respectively, and the binding constant to be ~1 x 10 -1° M for both L(M) and HeLa cells. Discussion Purified ~25I-labeled TNF(LuKII) bound specifically to saturable high affinity receptors present on cell lines sensitive to the cytotoxic effect of TNF(LuKII) or mouse TNF. Cell lines rendered resistant to TNF appeared to lack specific receptors for TNF(LuKII). At 4°C, the binding of radiolabeled TNF(LuKII) to sensitive cells reached equilibrium after 4 h of exposure, while, at 37°C, the amount of TNF(LuKII) bound to the cells continued to increase over 8 h. These results suggest possible uptake or metabolism of the radiolabeled TNF(LuKII) at 37°C.
Mouse serum TNF competes with TNF(LuKII) for receptor binding on both mouse and human cell lines. Since the mouse TNF preparation used in these studies was not pure, the competition observed may be due to the contaminants. However, the observation that equal numbers of units of TNF(LuKII) and mouse TNF result in a similar degree of competition and that preparations of mouse TNF with different specific activities compete to an equivalent extent (data not shown) suggest that mouse TNF molecules are competing with TNF(LuKII) for receptor binding. It will be important to carry out a similar receptor studies with recombinant human TNF (8-10) and nonrecombinant and recombinant human lymphotoxin (11, 12) to determine whether a common receptor exists for these various cytotoxic factors.
Under denaturing conditions, TNF(LuKII) is observed to exist in molecular weight forms ranging from 80,000 to 19,000 (3) and, under nondenaturing conditions, as a 70,000 tool wt molecule. We have used this latter value to calculate the number of receptors per cell and the binding constant of the receptor. The number of receptors would be higher if we calculated on the basis of the lower molecular weight forms of TNF(LuKII). 
